KIT and intrahepatic cholangiocarcinoma: In the jejunum, we observed KIT+/MCT−/VIM+ ICC in the TME and KIT+/MCT+ mast cells in the TM, which confirms the specificity of the KIT antibody clones (Figs 4, 5).